Authors
Latest:
Consequences of Brexit for Clinical Trials in EuropeHigher costs headline list of new challenges faced by CROs and sponsors.
Latest:
RBM—An Update of Experiences Among European CRAsAn RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.
Latest:
Cancer Trials: Raising Accrual RatesLessons learned from the recruitment of colorectal cander patients into clinical trials.
Latest:
The Risk Based Monitoring PlanSponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.
Latest:
Strategic Partnerships EvolveGreater product value and innovation accomplished with sponsor-service relationships.
Latest:
Achieving Optimal Adoption of Risk-Based Quality ManagementThe need to boost education, shift culture, and embrace new technologies.
Latest:
Through the Patient Perspective: Collaborating to Improve Research and DevelopmentAt the October Metrics in Patient Centered Drug Development conference hosted by DIA, many of these key constituents gathered to talk about how to implement and measure the impact of patient input.
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
A Roadmap for Implementing RBM and Quality ManagementThe importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
A Roadmap for Implementing RBM and Quality ManagementThe importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.
Latest:
Impact of FDA Project FrontRunner on Oncology Drug DevelopmentWebinar Date/Time: Tuesday, December 10th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Latest:
Machine Learning within the Clinical Trial ProcessMachine learning technology is finding it’s way into today’s marketplace, specifically within business processes, by driving insurmountable value for corporations within the life science industry, writes Adam Ross Miller.
Latest:
US Clinical Investigator ExperienceThis data analysis takes a look at how much experience US clinical investigators have.
Latest:
Three Steps to A Successful Combination Product TrialSponsors can streamline the design and execution of their clinical trials by following this three-step approach.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
Estimands and Implications for Sponsors as ICH E9 (R1) Addendum ProgressesSponsors should be aware of the significant implications the Addendum is likely to have on clinical trial planning, conduct, statistical analysis, and interpretation.
Latest:
Why We Should Talk to Patients Who Drop Out of Clinical TrialsSandy Chase focuses on the voice of the patient and their experience after not completing a clinical trial.
Latest:
Improving the Traceability of the Clinical Trial Supply ChainOutlining the benefits of using blockchain technology across the supply chain to more securely record and distribute data to sites.
